Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wajsbort

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|April 6, 1972
Post-menopausal bleeding after L-dopaJ Wajsbort
Journal of Neurology|April 28, 1977
[The "off-on" phenomenon during treatment of parkinson's disease with levodopa (author's transl)]J Wajsbort
Harefuah|February 15, 1971
[Treatment of neurosyphilis]J Tempski-Templehof, J Wajsbort
Advances in Neurology|January 1, 1984
A new selective suicide inhibitor of peripheral DOPA decarboxylaseJ Wajsbort, M B Youdim
Current Medical Research and Opinion|January 1, 1978
A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's diseaseJ Wajsbort, A Dorner, E Wajsbort
Archives of Pathology|March 1, 1973
Levodopa and malignant melanomaE Robinson, J Wajsbort, B Hirshowitz
Israel Journal of Medical Sciences|August 1, 1973
Effect of L-DOPA on transplanted malignant melanomas in miceE Robinson, J Wajsbort, T Mekori
Communications in Psychopharmacology|January 1, 1980
Deprenyl does not cause insomnia in parkinsonian patientsP Lavie, J Wajsbort, M B Youdim
Progress in Medicinal Chemistry|January 1, 1984
Monoamine oxidase type B inhibitors in the treatment of Parkinson's diseaseM B Youdim, J P Finberg, J Wajsbort
Wiener Medizinische Wochenschrift (1946)|October 16, 1971
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]J Wajsbort, J A Hemli, I Alfandary, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|April 6, 1972
Post-menopausal bleeding after L-dopaJ Wajsbort
Journal of Neurology|April 28, 1977
[The "off-on" phenomenon during treatment of parkinson's disease with levodopa (author's transl)]J Wajsbort
Harefuah|February 15, 1971
[Treatment of neurosyphilis]J Tempski-Templehof, J Wajsbort
Advances in Neurology|January 1, 1984
A new selective suicide inhibitor of peripheral DOPA decarboxylaseJ Wajsbort, M B Youdim
Current Medical Research and Opinion|January 1, 1978
A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's diseaseJ Wajsbort, A Dorner, E Wajsbort
Archives of Pathology|March 1, 1973
Levodopa and malignant melanomaE Robinson, J Wajsbort, B Hirshowitz
Israel Journal of Medical Sciences|August 1, 1973
Effect of L-DOPA on transplanted malignant melanomas in miceE Robinson, J Wajsbort, T Mekori
Communications in Psychopharmacology|January 1, 1980
Deprenyl does not cause insomnia in parkinsonian patientsP Lavie, J Wajsbort, M B Youdim
Progress in Medicinal Chemistry|January 1, 1984
Monoamine oxidase type B inhibitors in the treatment of Parkinson's diseaseM B Youdim, J P Finberg, J Wajsbort
Wiener Medizinische Wochenschrift (1946)|October 16, 1971
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]J Wajsbort, J A Hemli, I Alfandary, et al.
Pageof 2